Patents by Inventor Michael Cope
Michael Cope has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11962903Abstract: Aerial camera systems are disclosed, including an aerial camera system that comprises at least one camera arranged to capture a plurality of successive images; the at least one camera being rotatable such that the field of view of the camera traverses across a region of the ground that includes multiple different swathes extending in different directions, the at least one camera having a steering mirror to direct light reflected from the ground onto a lens assembly, the lens assembly having a central longitudinal axis extending in a direction generally parallel to a direction of movement of a survey aircraft; and the system arranged to control the at least one camera to capture successive images at defined intervals as the at least one camera rotates.Type: GrantFiled: April 15, 2022Date of Patent: April 16, 2024Assignee: Spookfish Innovation PTY LTDInventors: Simon Cope, Michael Von Bertouch
-
Patent number: 11932512Abstract: A method of communication between a robot and an elevator system using a robot communication system including: collecting data on a landing of a building using a sensor system of the robot; and transmitting the data to the elevator system of the building, the data being transmitted to the elevator system directly from the robot, through a cloud computing network, or through a building system manager.Type: GrantFiled: March 16, 2020Date of Patent: March 19, 2024Assignee: OTIS ELEVATOR COMPANYInventors: Stephen Richard Nichols, Bradley Armand Scoville, Michael P. Keenan, Jr., Nicholas Cope, James Sorrels, Mohip Joarder
-
Publication number: 20200410880Abstract: A dining surface preparation apparatus and system is provided. The apparatus includes a base. The base is configured to interface with a dining surface area. The dining surface preparation apparatus also includes an item identification system. The item identification apparatus is positionable on the base and is arranged to provide identification of dining items. Additionally, the dining surface preparation apparatus includes an item location system. The item location system is positionable on the base and is configured to provide location of dining items on the dining surface area.Type: ApplicationFiled: June 28, 2019Publication date: December 31, 2020Inventor: Michael Cope
-
Publication number: 20140223812Abstract: An apparatus configured for dispensing grains of pollen may include a pollen storage container, a flow source configured to dispense the grains of pollen from the pollen storage container, and a control mechanism configured to selectively activate the flow source. The apparatus may or may not apply an electrical charge to the grains of pollen. Related methods may include steps of collecting pollen, inserting the pollen into a pollen storage container, connecting the pollen storage container to a dispensing device such as the above-described apparatus, and dispensing the pollen from the pollen storage container with the dispensing device. Known grains of pollen may be dispensed to create predetermined gamete crosses with known plants. Further, an outlet of a fan which dispenses the pollen from the pollen storage container or other parts of the dispensing device may be cleaned when swapping the pollen storage container to prevent cross-contamination.Type: ApplicationFiled: March 20, 2012Publication date: August 14, 2014Applicant: Pioneer Hi Bred International, Inc.Inventors: Jason Michael Cope, Bradley Thomas McAvoy
-
Publication number: 20140115730Abstract: A method for sorting pollen containing genetic elements of interest may include associating a genetic marker with seeds defining the genetic elements of interest, growing plants from the seeds, collecting pollen from the seeds, evaluating the pollen for presence of the genetic markers, and sorting the pollen based on presence or absence of the genetic markers. A method of determining viability of pollen may evaluate the optical density of grains of pollen and compare the optical density to an optical density threshold. Further, a method for identifying plants defining a genetic marker with seeds defining the genetic element of interest, growing plants from the seeds, and evaluating the plants for presence of the genetic marker.Type: ApplicationFiled: March 20, 2012Publication date: April 24, 2014Applicant: Pioneer Hi-Bred International, Inc.Inventor: Jason Michael Cope
-
Publication number: 20140054184Abstract: A seed handling tool includes a handle connected to a working body. The working body includes a working surface, which further includes a plurality of seed retention points. A seed retention source is provided to allow the seed handling tool to pick up and retain seeds at the seed retention points. In some embodiments, the seeds may also be released from the seed retention points. A method for retaining a plurality of seeds by the seed handling tool includes moving the seed handling tool to a position where the working surface is adjacent to a plurality of seeds, and picking up and retaining seeds at a plurality of seed retention points fixed at the working surface. In some embodiments, the method may also include releasing the plurality of seeds from the seed retention points.Type: ApplicationFiled: November 5, 2013Publication date: February 27, 2014Applicant: Pioneer Hi Bred International Inc.Inventors: Steven Michael Becker, Bruce E. Cadwell, Jason Michael Cope, Gary L. Jaehnel, David Dallinger Kurth
-
Publication number: 20080021049Abstract: The present invention provides methods and compositions for the treatment of phospholipase-related conditions. In particular, the invention provides a method of treating insulin-related, weight-related conditions and/or cholesterol-related conditions in an animal subject. The method generally involves the administration of a phospholipase A2 inhibitor having comprising a substituted organic compound having a fused five-member ring and six-member ring, such as indole-containing compounds.Type: ApplicationFiled: May 3, 2005Publication date: January 24, 2008Inventors: Jerry Buysse, Dominique Charmot, Han-Ting Chang, Michael Cope, David Hui
-
Publication number: 20070292385Abstract: The present invention provides methods and compositions for the treatment of phospholipase-related conditions. In particular, the invention provides a method of treating insulin-related, weight-related conditions and/or cholesterol-related conditions in an animal subject. The method generally involves the administration of a non-absorbed and/or effluxed phospholipase A2 inhibitor that is localized in a gastrointestinal lumen.Type: ApplicationFiled: May 3, 2005Publication date: December 20, 2007Inventors: Dominique Charmot, Jerry Buysse, Han-Ting Chang, Michael Cope, David Hui
-
Publication number: 20070135383Abstract: The present invention provides methods and compositions for the treatment of phospholipase-related conditions. In particular, the invention provides a method of treating insulin-related, weight-related conditions and/or cholesterol-related conditions in an animal subject. The method generally involves the administration of a non-absorbed and/or effluxed phospholipase A2 inhibitor that is localized in a gastrointestinal lumen.Type: ApplicationFiled: November 3, 2006Publication date: June 14, 2007Inventors: Han-Ting Chang, Dominque Charmot, Tomasz Glinka, Michael Cope, Elizabeth Goka, Jun Shao, Damien Cartigny, Shiah-yun Chen, Jerry Buysse
-
Publication number: 20070135385Abstract: Indole and indole-related compounds, compositions and methods are disclosed. The compounds of the invention are useful as phospholipase inhibitors. The compounds and compositions of the invention are useful for treatment of phospholipase-related conditions, such as insulin-related, weight-related and/or cholesterol-related conditions in an animal subject.Type: ApplicationFiled: November 3, 2006Publication date: June 14, 2007Inventors: Han-Ting Chang, Dominique Charmot, Tomasz Glinka, Michael Cope, Elizabeth Goka, Jun Shao, Damien Cartigny, Shiah-yun Chen, Jerry Buysse
-
Publication number: 20070041911Abstract: This invention relates to stabilized aerosol solution formulations containing acid addition salts of salbutamol, which are suitable for administration by metered dose inhalers (MDIs). More particularly, this invention relates to solution formulations containing one of the aforementioned salts of salbutamol, preferably salbutamol hydrochloride or salbutamol citrate, more preferably one of the two before mentioned salts in combination with one or more additional pharmacologically active substances, together with an environmentally safe hydrofluorocarbon (HFC) as a propellant, a co-solvent, preferably an organic compound as a co-solvent, and either an inorganic acid or an organic acid.Type: ApplicationFiled: August 9, 2006Publication date: February 22, 2007Inventors: Friedrich Schmidt, Mariola Mann, Michael Cope, Holger Memmesheimer
-
Publication number: 20060099169Abstract: Methods and compositions for the treatment of toxin-mediated diseases are provided herein. One aspect of the invention is oligosaccharide-based therapeutics that interact with toxins and methods of uses thereof. In one embodiment the oligosaccharide-based therapeutics of the invention comprise polymeric particles with attached oligosaccharide binding moieties. The compositions of the invention can be used in the treatment of toxin-mediated diseases such as antibiotic-associated diarrhea and pseudomembranous colitis, including Clostridium difficile associated diarrhea.Type: ApplicationFiled: October 13, 2005Publication date: May 11, 2006Applicant: Ilypsa, Inc.Inventors: Dominique Charmot, Jerry Buysse, Han Chang, Michael Cope, Tony Mong, Elizabeth Goka
-
Publication number: 20060078534Abstract: Methods and compositions for the treatment of toxin-mediated diseases are provided herein. One aspect of the invention is oligosaccharide-based therapeutics that interact with toxins and methods of uses thereof. In one embodiment the oligosaccharide-based therapeutics of the invention comprise polymeric particles with attached oligosaccharide binding moieties. The compositions of the invention can be used in the treatment of toxin-mediated diseases such as antibiotic-associated diarrhea and pseudomembranous colitis, including Clostridium difficile associated diarrhea.Type: ApplicationFiled: October 13, 2004Publication date: April 13, 2006Inventors: Dominique Charmot, Jerry Buysse, Han Chang, Tony Mong, Michael Cope, Elizabeth Goka
-
Publication number: 20060024265Abstract: The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising sodium-binding polymers and pharmaceutical compositions thereof. Methods of use of the polymeric and pharmaceutical compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, chronic renal insufficiency, fluid overload, or sodium overload.Type: ApplicationFiled: March 30, 2005Publication date: February 2, 2006Inventors: Robert Alpern, Jerry Buysse, Han Chang, Dominique Charmot, Michael Cope, John Fordtran, Gerrit Klaerner
-
Publication number: 20050220751Abstract: The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising potassium binding polymers and pharmaceutical compositions thereof. Methods of use of the polymeric and pharmaceutical compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of hyperkalemia, such as hyperkalemia caused by renal failure and/or the use of hyperkalemia causing drugs.Type: ApplicationFiled: October 13, 2004Publication date: October 6, 2005Inventors: Dominique Charmot, Han Chang, Gerrit Klaerner, Michael Cope, Mingjun Liu, Futian Liu
-
Publication number: 20050220752Abstract: The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising potassium binding polymers and pharmaceutical compositions thereof. Methods of use of the polymeric and pharmaceutical compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of hyperkalemia, such as hyperkalemia caused by renal failure and/or the use of hyperkalemia causing drugs.Type: ApplicationFiled: March 30, 2005Publication date: October 6, 2005Inventors: Dominique Charmot, Han Chang, Gerrit Klaerner, Michael Cope, Mingjun Liu, Futian Liu, Kwok-Kong Mong
-
Publication number: 20050220750Abstract: The present invention provides methods and compositions for the treatment of ion imbalances. In particular, the invention provides compositions comprising sodium-binding polymers and pharmaceutical compositions thereof. Methods of use of the polymeric and pharmaceutical compositions for therapeutic and/or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, chronic renal insufficiency, fluid overload, or sodium overload.Type: ApplicationFiled: March 30, 2004Publication date: October 6, 2005Applicant: Symyx Therapeutics, Inc.Inventors: Alpern Robert, Jerry Buysse, Han Chang, Dominique Charmot, Michael Cope, John Fordtran, Gerrit Klaerner